-
公开(公告)号:DE69814441D1
公开(公告)日:2003-06-12
申请号:DE69814441
申请日:1998-10-29
Applicant: ABBOTT LAB
Inventor: OR SUN , GRIESGRABER GEORGE , LI LEPING , CHU T
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , C07H17/00 , A61K31/70
Abstract: Novel 6,11-bridged erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II); compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier; a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention; and processes for their preparation.
-
公开(公告)号:DE69626040D1
公开(公告)日:2003-03-06
申请号:DE69626040
申请日:1996-11-06
Applicant: ABBOTT LAB
Inventor: OR SUN , CHU T , ELLIOTT L , PIREH DAISY
IPC: A61K31/00 , A61K31/70 , A61K31/7042 , A61K31/7048 , A61P31/00 , A61P31/04 , C07H17/08
Abstract: A compound selected from groups (I), (II), and (III), wherein A, B, V, W, X and R are specifically defined; pharmaceutical compositions thereof; a method of treating or preventing bacterial infections by administering therapeutically effective pharmaceutical compositions thereof; and a process for the preparation thereof.
-
公开(公告)号:DE69830739T2
公开(公告)日:2006-04-20
申请号:DE69830739
申请日:1998-10-29
Applicant: ABBOTT LAB
IPC: C07H17/08 , A61K31/70 , A61K31/7042 , A61K31/7048 , A61P31/04
Abstract: Novel 2-halo-6-O-substituted ketolide derivatives and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for their preparation.
-
公开(公告)号:DE69830739D1
公开(公告)日:2005-08-04
申请号:DE69830739
申请日:1998-10-29
Applicant: ABBOTT LAB
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , A61K31/70
Abstract: Novel 2-halo-6-O-substituted ketolide derivatives and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for their preparation.
-
公开(公告)号:DE69821009T2
公开(公告)日:2004-11-18
申请号:DE69821009
申请日:1998-09-01
Applicant: ABBOTT LAB
Inventor: OR SUN , CLARK F , CHU T , PLATTNER J
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , A61K31/70
Abstract: Novel multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula (I) (II), (III), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention.
-
公开(公告)号:DE69132348T2
公开(公告)日:2001-03-15
申请号:DE69132348
申请日:1991-05-01
Applicant: ABBOTT LAB
Inventor: CHU T , LEE M , LI QUN , COOPER S , PLATTNER J
IPC: A61K31/435 , A61K31/47 , A61K31/505 , A61K31/535 , A61K31/54 , A61K38/00 , A61P31/04 , C07D213/68 , C07D455/02 , C07D471/04 , C07D471/08 , C07D491/10 , C07D491/16 , C07D495/16 , C07D519/00 , C07K5/06 , A61K31/495 , C07D471/16
-
公开(公告)号:DE69132348D1
公开(公告)日:2000-09-07
申请号:DE69132348
申请日:1991-05-01
Applicant: ABBOTT LAB
Inventor: CHU T , LEE M , LI QUN , COOPER S , PLATTNER J
IPC: A61K31/435 , A61K31/47 , A61K31/505 , A61K31/535 , A61K31/54 , A61K38/00 , A61P31/04 , C07D213/68 , C07D455/02 , C07D471/04 , C07D471/08 , C07D491/10 , C07D491/16 , C07D495/16 , C07D519/00 , C07K5/06 , A61K31/495 , C07D471/16
-
公开(公告)号:DE69733422D1
公开(公告)日:2005-07-07
申请号:DE69733422
申请日:1997-09-02
Applicant: ABBOTT LAB
Inventor: OR SUN , MA ZHENKUN , CLARK F , CHU T , PLATTNER J
IPC: A61K31/70 , A61K31/7048 , A61P31/04 , C07H17/00 , C07H17/08
Abstract: 6-Substituted ketolides of e.g. formula (II) or (III), and their salts, esters and prodrugs are new: Y + Z = X; X = OH, =NOR1 or =NOC(R5)(R6)OR1; or one of Y and Z = H; and the other = H, OH, protected OH or NR7R8; R1 = 1-12C alkyl (optionally substituted), 3-12C cycloalkyl or SiR2R3R4; R2-R4 = 1-12C alkyl or aryl; R5, R6 = H or 1-12C alkyl (optionally substituted), or R5 + R6 = 3-12C cycloalkyl; R7, R8 = H or 1-6C alkyl; or NR7R8 = 3-7 membered ring which, when the ring is 5-7 membered may optionally contain O, NH, N(1-6C alkyl), N(aryl), N(aryl-1-6C alkyl), N (substituted aryl-1-6C alkyl), N(heteroaryl), N(heteroaryl-1-6C alkyl), N(substituted heteroaryl-1-6C alkyl), S or S(O)n; n = 1 or 2; Ra = H or OH; Rc = H or hydroxy protecting group; R9 = 1-6C alkyl (optionally substituted), 3-7C cycloalkyl or optionally substituted aryl or heteroaryl; M = CONH, NHCO, NH, N=, NMe, NHCOO, NHCONH, OCONHY, OCOO, O, S(O)n, COO, OCO or CO; R = methyl (substituted by CN, F, CO2R10, S(O)nR10, NHCOR10, NHCONR11R12, aryl, substituted aryl, heteroaryl or substituted heteroaryl); 2-10C alkyl (optionally substituted), 3C alkenyl (substituted by halo, CHO, CO2R10, COR9, CONR11R12, CN, optionally substituted aryl or heteroaryl, 3-7C cycloalkyl or 1-12C alkyl substituted by heteroaryl); 4-10C alkenyl (optionally substituted), or 3-10C alkynyl optionally substituted); R10 = 1-3C alkyl (optionally aryl substituted), or heteroaryl substituted 1-3C alkyl; R11, R12 = H or 1-3C alkyl (optionally substituted); A, B, D, E = H, 1-6C alkyl (optionally substituted by optionally substituted), 3-7C cycloalkyl, optionally substituted aryl or heteroaryl, heterocycloalkyl or 1-6C alkyl substituted by MR9; provided that \- 2 of A, B, D and E = H; or any one pair of substituents, consisting of AB, AD, AE, BD, BE or DE taken with the atoms to which they are attached, form a 3- to 7-membered ring optionally containing O, NH, N(1-6C alkyl), N(aryl-1-6C alkyl), N(substituted aryl-1-6C alkyl), N(heteroaryl-1-6C alkyl), N(substituted heteroaryl-1-6C alkyl), S, S(O)n, CONH, CONR12, NHCO, NR12CO or C(=NH)NH.
-
公开(公告)号:DE69814441T2
公开(公告)日:2004-04-08
申请号:DE69814441
申请日:1998-10-29
Applicant: ABBOTT LAB
Inventor: OR SUN , GRIESGRABER GEORGE , LI LEPING , CHU T
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , C07H17/00 , A61K31/70
Abstract: Novel 6,11-bridged erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I) or (II); compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier; a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention; and processes for their preparation.
-
公开(公告)号:DE69631609D1
公开(公告)日:2004-03-25
申请号:DE69631609
申请日:1996-10-17
Applicant: ABBOTT LAB
Abstract: Compounds, or pharmaceutically acceptable salts and esters thereof, of formulae (I); (II); (III) or (IV) wherein A, B, D and E, R , R and Z are specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of antibacterial infections with such compositions, and processes for the preparation of the compounds.
-
-
-
-
-
-
-
-
-